Boyle, David L.
DePrimo, Samuel E.
Calderon, Cesar
Chen, Dion
Dunford, Paul J.
Barchuk, William
Firestein, Gary S.
Thurmond, Robin L.
Funding for this research was provided by:
Janssen Research and Development (n/a)
Article History
Received: 15 November 2018
Revised: 23 January 2019
Accepted: 25 January 2019
First Online: 9 February 2019
Compliance with ethical standards
:
: SE DePrimo, C Calderon, D Chen, PJ Dunford*, W Barchuk*, and RL Thurmond are/were employees of Janssen, a Johnson and Johnson (J&J) Pharmaceutical Company, and own stock in J&J. DL Boyle and GS Firestein have each received research grant funding from Janssen. *These authors were employed by Janssen at the time this study was conducted.
: All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional review board and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained for all individual participants included in the study.